Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Teva
Fish and Richardson
Baxter
Cantor Fitzgerald
Boehringer Ingelheim
Deloitte
US Department of Justice
Chinese Patent Office

Generated: June 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018063

« Back to Dashboard

NDA 018063 describes CORGARD, which is a drug marketed by Us Worldmeds Llc and is included in one NDA. It is available from three suppliers. Additional details are available on the CORGARD profile page.

The generic ingredient in CORGARD is nadolol. There are five drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the nadolol profile page.
Summary for 018063
Tradename:CORGARD
Applicant:Us Worldmeds Llc
Ingredient:nadolol
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 018063
Mechanism of ActionAdrenergic beta-Antagonists
Medical Subject Heading (MeSH) Categories for 018063
Suppliers and Packaging for NDA: 018063
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CORGARD nadolol TABLET;ORAL 018063 NDA US WorldMeds, LLC 27505-100 N 27505-100-01
CORGARD nadolol TABLET;ORAL 018063 NDA US WorldMeds, LLC 27505-101 N 27505-101-01

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength40MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength80MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength120MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Expired US Patents for NDA 018063

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Us Worldmeds Llc CORGARD nadolol TABLET;ORAL 018063-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Us Worldmeds Llc CORGARD nadolol TABLET;ORAL 018063-002 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Us Worldmeds Llc CORGARD nadolol TABLET;ORAL 018063-003 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Us Worldmeds Llc CORGARD nadolol TABLET;ORAL 018063-005 Oct 28, 1986 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Fuji
US Department of Justice
Boehringer Ingelheim
Chinese Patent Office
Moodys
Colorcon
Harvard Business School
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.